Lamanna, W. C., Heller, K., Schneider, D., Guerrasio, R., Hampl, V., Fritsch, C., & Schiestl, M. (2017). The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion. J Oncol Pharm Pract.
Citação norma ChicagoLamanna, William C., Katharina Heller, Daniel Schneider, Raffaele Guerrasio, Veronika Hampl, Cornelius Fritsch, and Martin Schiestl. "The In-use Stability of the Rituximab Biosimilar Rixathon®/Riximyo® Upon Preparation for Intravenous Infusion." J Oncol Pharm Pract 2017.
Citação norma MLALamanna, William C., et al. "The In-use Stability of the Rituximab Biosimilar Rixathon®/Riximyo® Upon Preparation for Intravenous Infusion." J Oncol Pharm Pract 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.